$CLBT

Cellebrite Q2 Net Profit Plunges, Appoints Shiven Ramji As CEO; Stock Down Over 28% In Pre-Market

Cellebrite DI Ltd. (CLBT) reported Q2 FY2026 net income of $6.371M, or $0.02/share, down from $19.476M, or $0.08/share a year earlier, as operating expenses rose to $98.982M. Revenue increased to $131.138M, including $97.685M from subscription services. The company appointed Shiven Ramji as CEO and lowered FY2026 revenue guidance to $555M-$561M.

Original reporting
Published Aug 13, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 1:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cellebrite Q2 Net Profit Plunges, Appoints Shiven Ramji As CEO; Stock Down Over 28% In Pre-Market — source image
Decision brief

The 30-second read

$CLBTBearishMed
01

Why it matters

Net income and operating income fell sharply while operating expenses rose, and management reduced FY revenue guidance. The CEO change adds governance and execution uncertainty, while subscription revenue growth partially offsets the earnings deterioration.

02

Market read

Traders have a fresh catalyst set: Q2 earnings deterioration, FY revenue guidance cut, and an immediate CEO transition, all occurring alongside a large pre-market selloff.

03

What to watch

The article provides adjusted EBITDA and revenue ranges for Q3 and FY, which could stabilize expectations if investors focus on operating leverage rather than GAAP net income.

Relevance 8/10Novelty 7/10Timing: pre-market today, after Q2 results and FY guidance revision

Background

Cellebrite is a digital forensics company; the report covers Q2 fiscal 2026 results, a revised annual revenue outlook, and an immediate CEO succession.

Company-level read

Ticker impact

$CLBTBearishMedium confidence
Context

Cellebrite reported Q2 net income plunging to $6.371M, raised expenses, and cut annual revenue guidance while appointing a new CEO.

Expected impact

Further downside or high volatility is plausible until investors digest the revised revenue outlook and cost trajectory.

Evidence & confidence

The article discloses a sharp earnings deterioration, higher operating expenses, and reduced FY revenue guidance, alongside an immediate CEO change, all of which can re-rate risk and expectations.

Market effects

Digital forensics and government/enterprise software peers may see read-across on subscription durability and cost discipline.

Limited direct regional spillover; impact is primarily on US-listed software/defense-tech sentiment.

Moderate, as Cellebrite sells into global law-enforcement and enterprise markets, but the article is company-specific.

Counterpoint

Revenue rose and subscription revenue increased, so the selloff may over-discount temporary expense timing rather than a structural demand issue.

Key entities

  • Cellebrite DI Ltd.

    Reported Q2 fiscal 2026 results with sharply lower net income, higher expenses, increased subscription revenue, and revised down annual revenue guidance.

  • Shiven Ramji

    Appointed CEO effective immediately after joining as President, Products and Technology in May.

  • Thomas E. Hogan

    Stepped down as CEO, succeeded by Shiven Ramji.

Related articles

$CLBTHighAI 9/10

Why is Cellebrite stock plunging today?

Cellebrite (CLBT) shares fell about 28% in pre-open after Q2 2026 results and a leadership change. EPS was $0.11 vs $0.07 consensus, but revenue missed at $131.14M vs $131.87M. Guidance was cut: FY 2026 ARR to $550M-$560M and revenue to $550M-$560M, below $568M consensus. CEO change and a Form 144 insider sale added pressure.

$CPKMedAI 8/10

Chesapeake Utilities (CPK) Q2 2026 Earnings Call Transcript

Chesapeake Utilities (CPK) reported Q2 2026 adjusted net income of $25.4 million, up 5% year over year, and adjusted EPS of $1.05. Management raised 2026 capital guidance to $550 million to $600 million and expects 2028 EPS of $7.75 to $8.00. It also discussed the $1.2 billion Florida Energy Pathway project and reaffirmed efficiency and dividend plans.